Pharma-Bio Serv (PBSV) Gains from Investment Securities (2019 - 2021)
Pharma-Bio Serv (PBSV) posted Gains from Investment Securities of $1.2 million for Q1 2021, up 150.0% on a QoQ basis from $500000.0 in Q2 2019.
Pharma-Bio Serv (PBSV) Gains from Investment Securities (2019 - 2021) Analysis & Trends
Pharma-Bio Serv's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $1.2 million for Q1 2021.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $1.2 million in Q1 2021, while the trailing twelve-month figure through Oct 2021 was $1.2 million (changed N/A YoY) and the FY2021 annual result came in at $1.2 million, changed N/A from the prior year.
- Gains from Investment Securities was $1.2 million for Q1 2021 at Pharma-Bio Serv, up from $500000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.2 million in Q1 2021 and bottomed at $500000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 32.07 Bn | 24.76 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.69 Bn | 13.79 Bn | 482.22 Mn |
| 3 | Healthequity | 8.38 Bn | 8.12 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.95 Bn | 5.63 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.92 Bn | 5.38 Bn | 106.18 Mn |
| 6 | MiniMed | 4.50 Bn | 4.20 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.44 Bn | 4.38 Bn | 216.84 Mn |
| 8 | Doximity | 3.95 Bn | 3.21 Bn | 125.97 Mn |
| 9 | Privia Health | 3.11 Bn | 2.69 Bn | - |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2021 | 1.25 Mn |
| Jan 31, 2021 | 1.25 Mn |
| Apr 30, 2019 | 500,000.00 |
| Apr 30, 2019 | 500,000.00 |